For advanced squamous non-small cell lung cancer (NSCLC), V-Raf murine sarcoma viral oncogene homolog B1 (<i>BRAF</i>) fusions have not been evaluated as a therapeutic target. The gene discussed is BRAF; the disease is small cell lung carcinoma.